We are grateful to the federal and state government agencies, foundations, universities, and companies who have supported our research on nanovaccines, nanotherapeutics, and nanoparticles. Here is a current list of our recent sponsored projects.
Current Awards
Department of Defense (DOD)
“INNS: Integrated Neuroprotective and Neuroregenerative Strategies”
S Mallapragada, PI; A Kanthasamy, B Narasimhan, D Sakaguchi, Co-PIs 8/11–9/16
National Institutes of Health (NIH)
“Enhanced shelf-life nanovaccine formulation for immunity to biodefense pathogens”
B Narasimhan, PI; MJ Wannemuehler, BH Bellaire, TW Dubensky, and JM Hostetter, Co-PIs 9/14-8/18
National Science Foundation (NSF)
“REU Site: Biological Materials and Processes (BIOMAP)”
M Lamm, PI; B Narasimhan and others, Co-PI 2/16–2/19
U.S. Department of Agriculture (USDA)
“Next generation polyanhydride nanovaccine platform technology for poultry”
A Talaat, PI; B Narasimhan, Co-PI 5/16-4/19
“Nanoparticle delivery of antibiotics for disease control in cultured shrimp”
L Bartholomay, PI; B Narasimhan, B Bellaire, Co-PIs 5/15-4/18
Universities
Iowa State University
“Presidential Initiative for Interdisciplinary Research: Systems Design of Nanovaccines”
B Narasimhan, PI; S Carpenter, M Wannemuehler, T Dubensky, R Silberglitt, Co-PIs 7/13–12/16
Recently Completed Awards
Department of Defense (DOD)
“Targeted Nanovaccine Platforms Against Respiratory Pathogens”
S Mallapragada, PI; S Carpenter, B Narasimhan, N Pohl, M Wannemuehler, Co-PIs 9/10–9/14
“Synthetic Nanovaccines Against Respiratory Pathogens”
S Mallapragada, PI; B Narasimhan, M Wannemuehler, Co-PIs 7/09–6/13
“Novel Therapies for Pneumonic Plague Targeting Quorum Sensing Components”
F Minion, PI; B Narasimhan, D Nordman, G Phillips, K Rajan, M Wannemuehler, Co-PIs 9/06–3/13
Health Resources and Services Administration
“INOVA: Interdisciplinary Laboratory for Design, Discovery, and Testing of Vaccines and Anti-Microbials”
B Narasimhan, PI; P Nara, M Wannemuehler, Co-PIs 8/10–12/14
National Institutes of Health (NIH)
“Enhancing B Cell Immunity Against HIV-1 Using Novel Vaccine Delivery Platforms”
M Cho, PI; B Narasimhan, N Pohl, N Greenspan, T Waldschmidt, K Knight, Co-PI 8/10–10/14
“Impact of Polymer Adjuvant Chemistry on Adaptive Immune Mechanisms”
B Narasimhan, PI; B Bellaire, M Wannemuehler, Co-PIs 8/10–6/13
National Science Foundation (NSF)
“A 21st Century Revitalized Research and Research Training Infrastructure for Chemical and Biological Engineering”
S Mallapragada, PI; R Fox, B Narasimhan, B Shanks, J Shanks, Co-PIs 10/10–9/13
“Molecular Design of Nano-carrier Materials for Reactions Catalyzed by Multi-Enzyme Complexes”
S Mallapragada, PI; B Narasimhan, R Peters, Co-PIs 10/09–9/13
“REU Site: Biological Materials and Processes”
B Narasimhan, PI; M Lamm, Co-PI 3/12–2/15
Foundations
Bill and Melinda Gates Foundation
“Combination Anti-Filarial Treatments Using Amphiphilic Micro- and Nanoparticles”
B Bellaire, PI; R Martin, B Narasimhan, Co-PIs 5/13–10/14
State of Iowa Regents Innovation Fund
Evaluation of α-synuclein immunotherapeutics in animal models of Parkinson’s disease
B Narasimhan, PI; V Anantharam and M John, Co-PIs 9/14-5/16